ストックスクリーナーアプリを入手
269.48
0.71%
-1.9326
前日終値:
$271.41
開ける：
$268.02
24時間の取引高:
273.26K
Relative Volume:
0.27
時価総額：
$39.46B
収益：
$5.15B
当期純損益:
$1.40B
株価収益率:
28.34
EPS:
9.5082
ネットキャッシュフロー:
$1.65B
1週間 パフォーマンス:
-0.22%
1か月 パフォーマンス:
-1.36%
6か月 パフォーマンス:
+27.79%
1年 パフォーマンス:
+12.26%
1日の値動き範囲:
$266.31
$270.81
1週間の範囲:
$263.10
$273.75
52週間の値動き範囲:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
RMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
269.53 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ISRG
Intuitive Surgical Inc
|
464.43 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.10 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
75.64 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
279.48 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-18 | 開始されました | Citigroup | Buy |
| 2025-09-02 | アップグレード | CLSA | Hold → Outperform |
| 2025-07-15 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
Morgan Stanley Updates Rating and Price Target for ResMed (RMD) - GuruFocus
Morgan Stanley Adjusts Price Target on ResMed to $304 From $298, Maintains Overweight Rating - MarketScreener
Will ResMed Inc. outperform the marketJuly 2025 Short Interest & High Conviction Trade Alerts - newser.com
Will ResMed Inc. (RME) stock announce special dividendMarket Growth Summary & Real-Time Volume Trigger Notifications - newser.com
Is ResMed Inc. (RME) stock in buy zone after pullbackJuly 2025 Gainers & Growth Focused Entry Reports - newser.com
Why ResMed Inc. is moving todayWeekly Stock Summary & Entry Point Confirmation Signals - newser.com
How ResMed Inc. stock benefits from digital adoptionMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Will ResMed Inc. (RME) stock deliver compounding returns2025 Market Overview & Trade Opportunity Analysis - newser.com
Can ResMed Inc. (RME) stock sustain revenue momentumQuarterly Earnings Summary & Intraday High Probability Setup Alerts - newser.com
Is ResMed Inc. stock oversold or undervaluedGold Moves & Technical Entry and Exit Tips - newser.com
Historical volatility pattern of ResMed Inc. visualizedJuly 2025 Movers & Smart Allocation Stock Reports - newser.com
Is a relief rally coming for ResMed Inc. holdersTrend Reversal & Free Reliable Trade Execution Plans - newser.com
What margin trends mean for ResMed Inc. stockMarket Performance Summary & Fast Entry Momentum Alerts - newser.com
How ResMed Inc. (Common Stock) (RMEA) stock moves on employment data2025 Macro Impact & Verified Momentum Watchlists - newser.com
Will ResMed Inc. stock rise with strong economyAnalyst Upgrade & Weekly Top Stock Performers List - nchmf.gov.vn
Reversal indicators forming on ResMed Inc. stockWatch List & Fast Moving Stock Trade Plans - newser.com
Is ResMed Inc. (Common Stock) (RMEA) stock supported by free cash flowShort Setup & Long-Term Safe Investment Plans - nchmf.gov.vn
What recovery options are there for ResMed Inc.2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Zacks.com featured highlights include Stryker, NVIDIA, ResMed and Ralph Lauren - The Globe and Mail
What candlestick patterns are forming on ResMed Inc.Weekly Market Report & Safe Entry Trade Signal Reports - newser.com
Here's Why ResMed (RMD) is a Strong Growth Stock - sharewise.com
What to do if you’re stuck in ResMed Inc.Weekly Investment Report & Technical Confirmation Alerts - newser.com
How supply shortages influence ResMed Inc. (Common Stock) (RMEA) stockJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Quantitative breakdown of ResMed Inc. recent move2025 Risk Factors & Intraday High Probability Alerts - newser.com
ResMed Inc. stock trend forecastRate Hike & Scalable Portfolio Growth Ideas - newser.com
Is ResMed Inc. stock entering bullish territoryWeekly Risk Summary & Growth Focused Stock Pick Reports - newser.com
Growth Recap: Why ResMed Inc. stock could rally in 2025Short Setup & Reliable Breakout Stock Forecasts - nchmf.gov.vn
Published on: 2025-10-18 20:22:04 - nchmf.gov.vn
Insider Trends: What margin trends mean for ResMed Inc. stockSwing Trade & Verified Short-Term Plans - nchmf.gov.vn
How ResMed Inc. stock benefits from tech adoptionEarnings Beat & Consistent Income Trade Ideas - nchmf.gov.vn
How ResMed Inc. stock reacts to job market dataJuly 2025 Update & Real-Time Market Trend Scan - nchmf.gov.vn
Published on: 2025-10-18 13:16:53 - nchmf.gov.vn
Why ResMed Inc. stock could outperform in 2025Earnings Trend Report & Risk Controlled Swing Alerts - nchmf.gov.vn
Why retail investors favor ResMed Inc. stockBond Market & AI Optimized Trade Strategies - nchmf.gov.vn
Will ResMed Inc. (Common Stock) (RMEA) stock benefit from mergersWeekly Stock Report & Growth Oriented Trade Recommendations - nchmf.gov.vn
Published on: 2025-10-17 12:25:07 - newser.com
Buyout Rumor: Why ResMed Inc. stock remains on buy listsJuly 2025 Closing Moves & Safe Entry Momentum Tips - nchmf.gov.vn
ResMed Inc. Reports Increase in CHESS Depositary Interests for September 2025 - MSN
Trend Report: How ResMed Inc. stock reacts to job market dataMarket Activity Recap & AI Driven Price Predictions - nchmf.gov.vn
Analysts Offer Insights on Healthcare Companies: Zynex (ZYXI) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) - The Globe and Mail
ResMed Inc. (ASX:RMD)Shares, Dividends & News - intelligentinvestor.com.au
ResMed Inc. (RMD) Stock Forecasts - Yahoo Finance
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
1.44%
大文字化:
|
ボリューム (24 時間):